BridgeMD
New treatment option for Diabetes Mellitus
Official title Support-t Online Training in Youth Living With Type 1 Diabetes Transitioning to Adult Care
ClinicalTrials.gov ID: NCT05910840
What this study is testing
- What it's testing
- The investigators will conduct a randomized controlled trial (RCT) to examine how an online training and peer support platform could help the preparation to transition to adult care. Among 14-16 year old youth with Type 1 Diabetes (T1D), the investigators aim to assess the effect of an online training and peer support platform (Support-t) integrated in usual care, compared with usual care on Hemoglobin A1c (HbA1c), adverse outcomes and psychosocial measures during the preparation for transition to adult care.
- Time commitment: about 20 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 14 to 16
You may be able to join if
- Adolescents with a clinical diagnosis of T1D
- 14-16 years of age
- Receiving diabetes care at one of 4 university teaching hospital-based pediatric diabetes clinics in Quebec: Montreal Children's Hospital-McGill...
- Having access to internet
- Having an active email address
You likely can't join if
- Severe neurocognitive disabilities
- Patients with conditions associated with shortened erythrocyte survival, such as hemolytic anemia or other conditions associated with inaccurate HbA1c
See the full eligibility criteria
- Adolescents with a clinical diagnosis of T1D
- 14-16 years of age
- Receiving diabetes care at one of 4 university teaching hospital-based pediatric diabetes clinics in Quebec: Montreal Children's Hospital-McGill University Health Centre, Centre hospitalier universitaire de Sherbrooke...
- Having access to internet
- Having an active email address
- Fluent in English or French
- Severe neurocognitive disabilities
- Patients with conditions associated with shortened erythrocyte survival, such as hemolytic anemia or other conditions associated with inaccurate HbA1c
The study team makes the final eligibility decision.
Where it's taking place
- Gatineau, Canada
- Montreal, Canada
- Québec, Canada
- Sherbrooke, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 20 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 14 years to 16 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Gatineau, Canada; Montreal, Canada; Québec, Canada; Sherbrooke, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.